Registered Kenya · PPB

MGR-10 TABLETS

FLUNARIZINE

16920 FLUNARIZINE 10 MG PER TABLET GENERIC/BIOSIMILARS nervous system INN generic

What it does

Flunarizine is a medication that helps manage certain neurological conditions.

Commonly used for: migraine prevention, vestibular disorders (balance issues)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
16920
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FLUNARIZINE
Strength
-
Pack size
N/A
Therapeutic class
GENERIC/BIOSIMILARS
ATC class (WHO)
N07CA - Antivertigo preparations
Drug group
NERVOUS SYSTEM
RxNorm RxCUI
4459
Manufacturer / MAH
Sai Pharmaceuticals
Country of origin
FOREIGN
Manufacturer location
Whitefield Edge, Junction of James Gichuru Road and Olengurone Road Lavington Nairobi KE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:08:24 · updated 2026-03-23 04:53:33

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Flunarizine is a medication that helps manage certain neurological conditions.

What it treats

  • migraine prevention
  • vestibular disorders (balance issues)

How it works

Flunarizine works by blocking certain channels in the brain, which helps reduce the frequency of migraines and improve balance.

Who it's for

This medication is suitable for adults who experience frequent migraines or balance problems.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: flunarizine

BNF-referenced

Flunarizine is a selective calcium channel blocker primarily used in the management of migraine prophylaxis and the treatment of certain movement disorders, including vestibular disorders. It is also noted for its ability to enhance blood flow and reduce vascular resistance due to its action on calcium channels in vascular smooth muscle.

Indications

  • Migraine prophylaxis
  • Vestibular disorders
  • Movement disorders

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in paediatric patients.

Adults: For migraine prophylaxis, the usual adult dosage is 10 mg daily, which may be adjusted based on clinical response. For other indications, refer to specific guidelines.

Mechanism of action

Flunarizine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. This decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, leading to dilation of the coronary and systemic arteries, increased oxygen delivery to myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Pharmacodynamics

Flunarizine is a selective calcium entry blocker, possessing properties that allow it to bind to calmodulin. Additionally, it exhibits histamine H1 blocking activity, which may contribute to its therapeutic effects in migraine and motion sickness.

Pharmacokinetics

Flunarizine is well absorbed following oral administration, with peak plasma concentrations typically reached within a few hours. It exhibits a long half-life, allowing for once-daily dosing. The drug is extensively metabolized in the liver, and its metabolites are excreted primarily through urine. The pharmacokinetics may vary in individuals based on hepatic function.

Contra-indications

  • Hypersensitivity to flunarizine or any of its components
  • Parkinson's disease or other extrapyramidal disorders
  • Severe liver impairment
  • Pregnancy

Adverse effects

  • Drowsiness
  • Fatigue
  • Weight gain
  • Depression
  • Extrapyramidal symptoms
  • Dry mouth
  • Nausea
  • Abdominal pain
  • Insomnia

Interactions

  • May enhance the sedative effects of other CNS depressants
  • Caution with other antihypertensives due to additive blood pressure lowering effect
  • May interact with alcohol, increasing drowsiness

Precautions

  • Use with caution in patients with a history of depression
  • Monitor for signs of extrapyramidal symptoms
  • Consider gradual withdrawal to minimize rebound effects
  • Caution in patients with cardiovascular disorders

Pregnancy

Flunarizine is contraindicated in pregnancy due to potential risks to the fetus.

Breast-feeding

It is not known if flunarizine is excreted in human milk, caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Capsules of 5 mg
  • Capsules of 10 mg

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: flunarizine

PubChem CID 941361

Molecular formula: C26H26F2N2

Mechanism of action

Flunarizine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

Pharmacodynamics

Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.